Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?

Lakmini KB Mudduwa1 Department of Pathology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka, [email protected]Correspondence[email protected]

Gaya B Wijayaratne2 Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka

Harshini H Peiris3 Medical Laboratory Science Degree Program, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka

Shania N Gunasekera1 Department of Pathology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka, [email protected]

Deepthika Abeysiriwardhana1 Department of Pathology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka, [email protected]

Nimsha Liyanage1 Department of Pathology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka, [email protected]

Pages 329-335 | Published online: 26 Jun 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

DuffyMJCA 15-3 and related mucins as circulating markers in breast cancerAnn Clin Biochem199936Pt 557958610505206
PubMed Web of Science ®Google Scholar
ShimizuMYamauchiKIsolation and characterization of mucin-like glycoprotein in human milk fat globule membraneJ Biochem1982915155247068573
PubMed Web of Science ®Google Scholar
KufeDWMucins in cancer: function, prognosis and therapyNat Rev Cancer200991287488519935676
PubMed Web of Science ®Google Scholar
Taylor-PapadimitriouJBurchellJMilesDWDalzielMMUC1 and cancerBiochim Biophys Acta199914552–330131310571020
PubMed Web of Science ®Google Scholar
Al-azawiDKellyGMyersECA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancerBMC Cancer2006622016953875
PubMed Web of Science ®Google Scholar
DuffyMJEvoyDMcDermottEWCA 15-3: uses and limitation as a biomarker for breast cancerClin Chim Acta201041123–241869187420816948
PubMed Web of Science ®Google Scholar
HarrisLFritscheHMennelRAmerican Society of Clinical OncologyAmerican Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerJ Clin Oncol200725335287531217954709
PubMed Web of Science ®Google Scholar
DanieleADivellaRTrerotoliPClinical usefulness of cancer antigen 15-3 in breast cancer patients before and after surgeryOpen Breast Cancer J2013516
Google Scholar
Van PoznakCLyndsayNHarrisMDSomerfieldMRUse of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology Clinical Practice GuidelineJ Oncol Pract20151151451629424583
PubMed Web of Science ®Google Scholar
MartínACorteMDAlvarezAMPrognostic value of preoperative serum CA15-3 levels in breast cancerAnticancer Res2006265B3965397117094428
PubMed Web of Science ®Google Scholar
DuffyMJDugganCKeaneRHigh preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancerClin Chem200450355956314726467
PubMed Web of Science ®Google Scholar
GoldhirschAWinerEPCoatesASPanel membersPersonalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2013Ann Oncol20132492206222323917950
PubMed Web of Science ®Google Scholar
TangPTseGMImmunohistochemical surrogates for molecular classification of breast carcinoma: a 2015 updateArch Pathol Lab Med2016140880681427472239
PubMed Web of Science ®Google Scholar
SchnittSJClassification and prognosis of invasive breast cancer: from morphology to molecular taxonomyMod Pathol201023Suppl 2S60S6420436504
PubMed Web of Science ®Google Scholar
RakhaEAPitfalls in outcome prediction of breast cancerJ Clin Pathol201366645846623618694
PubMed Web of Science ®Google Scholar
MolinaRBarakVvan DalenATumor markers in breast cancer – European group on tumor markers recommendationsTumor Biol2005266281293
PubMedGoogle Scholar
DuffyMJBiochemical markers in breast cancer: which ones are clinically useful?Clin Biochem200134534735211522269
PubMed Web of Science ®Google Scholar
ShaoYSunXHeYLiuCLiuHElevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancerPLoS One2015107e013383026207909
PubMed Web of Science ®Google Scholar
GuadagniFFerroniPCarliniSRe-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyClin Cancer Res2001782357236211489813
PubMed Web of Science ®Google Scholar
YerushalmiRTyldesleySKenneckeHTumour markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcomeAnn Oncol201223233834521543625
PubMed Web of Science ®Google Scholar
LeeJSParkSParkJMChoJHKimSIParkBWElevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancerAnn Oncol20132451225123123230137
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date